Verisante Technologies Detects Skin Cancer in Less Than A Second

OneMedRadio interviewed Thomas Braun, CEO of Verisante Technologies [CVE:VRS], a medical device company committed to commercializing innovative systems for the early detection of cancer.

Read more »